Health
Novartis' Pelacarsen Fails to Deliver in Key Cardiovascular Trial
By Editor • September 4, 2026 • 1 min read
Novartis' pelacarsen, an experimental drug for heart disease, failed to show efficacy in a pivotal study, disappointing hopes for a new treatment.
Read more